Aventis Triumphs In Patent Suit Over ALS Drug
Impax announced Friday that the Delaware federal court has validated the patent on the grounds of anticipation. The court had already thrown out Impax's claims that the patent was acquired by inequitable conduct.
Impax had argued that previous research covered by another Aventis patent, U.S. Patent Number 5,236,940, had anticipated the use...
To view the full article, register now.